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Abstract
Background: Despite the low early mortality of Fontan procedures, Fontan patients are prone to vari-
ous cardiac and extra-cardiac complications in the long term. This may influence patient perception 
of their health and outcome. The aim of the study was to assess the relationship of multi-organ compli-
cations and physical efficiency with self-reported health-related quality of life (QOL) in adult Fontan 
patients.
Methods: Quality of life was assessed with the Short Form-36 questionnaire. Laboratory tests were 
done together with echocardiography, plethysmography, and cardiopulmonary exercise test. 
Results: The QOL was poorer in patients than in control subjects. The physical characteristics of 
patients correlated with dynamic ventilatory parameters, heart rate at the peak of exercise, alanine 
aminotransferase and albumin level. 
Conclusions: Liver impairment and chronotropic incompetence during exercise are associated with 
poor QOL in patients after Fontan procedure. In these patient, hepatic, pulmonary and cardiac functions  
should be carefully monitored. (Cardiol J 2018; 25, 1: 72–80)
Key words: adult Fontan patients, quality of life, SF-36, exercise tolerance, pulmonary 
function test, multiorgan complications
Introduction
The Fontan procedure, initially performed in 
1971, is used to repair univentricular hearts [1]. 
Before 1971, less than 20% of children with cardiac 
malformations reached adulthood [2]. However, 
advances in cardiac surgery have considerably 
increased the life expectancy of univentricular 
patients. Nowadays, almost 85% of patients with 
congenital heart disease (CHD) reach adulthood 
[3]. It is predicted that 20 years from now, CHD 
will be seen more commonly in adult patients than 
in pediatric patients [4]. 
In spite of low early mortality after Fontan pro-
cedure, patients are prone to several complications in 
long term, including arrhythmias, thrombo embolism, 
heart failure, pulmonary hypertension, cyanosis, 
liver dysfunction, protein-losing enteropathy, and 
restrictive lung diseases [5–10]. The occurrence 
of these complications and need for hospitalization 
influences the life expectancy and emotional, behav-
ioral, and psychosocial condition of these patients. 
Additionally, the patients’ quality of life (QOL) and 
perception of their health status also influence 
treatment outcomes [11, 12]. Therefore, patients’ 
perceived physical and mental health should be taken 
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into account to optimize treatment. There are only 
a few studies on patient QOL after Fontan procedure 
(Fontan patients) and non of them included patients 
with systemic complications [11–14, 40].
The aim of this study was to investigate the 
relationship between patient characteristics includ-
ing: medical history, physical examination, hema-
tologic, hepatic, and renal complications, physical 




Forty patients, older than 18 years, with Fon-
tan operation, who were clinically stable in the 
3 months prior to enrollment were included. Patients 
with any of the following were excluded: asthma, 
use of vasodilators for pulmonary hypertension, 
neoplasia, infection, inflammation, major trauma, 
pregnancy, diabetes, or alcohol abuse. Forty healthy 
volunteers, matched with patients by gender and 
age, were selected as controls.
Study protocol
Information on the following was recorded 
for each participant in the study: New York Heart 
Association (NYHA) functional class, vital signs, 
weight, height, type of cardiac malformation, his-
tory of cardiac operations, age at surgical repair, 
laboratory tests, echocardiography, oxygen satu-
ration, body plethysmography, cardiopulmonary 
exercise test (CPET), and self-reported health-
related QOL questionnaire.
The study protocol was approved by the lo-
cal Ethics Committee. Each participant provided 
informed consent to participate in this study.
Laboratory investigations
The following laboratory tests were performed: 
red blood cell counts, hematocrit, hemoglobin, red 
blood cell distribution width, iron level, B-type natriu-
retic peptide, albumin level, alanine aminotrans-
ferase (ALT), creatinine level, and cystatin C.
Cardiopulmonary exercise test and  
echocardiography 
Each participant underwent CPET with 
a modified Bruce protocol to evaluate exercise tol-
erance. The following parameters were recorded: 
time of exercise (T), heart rate (HR), blood pres-
sure (BP), ventilatory equivalent (VE), maximum 
oxygen uptake (VO2max), respiratory exchange ratio 
(RER), maximum ventilatory equivalent of oxygen 
(VE/VO2), maximum ventilatory equivalent of car-
bon dioxide (VE/VCO2), breathing reserve (BR), 
and oxygen saturation. Maximum oxygen uptake 
(VO2max) was defined as the highest value at peak 
workload in ml/kg/min and percentage of predicted 
value. Ventilatory anaerobic threshold (VAT) was 
measured by use of V-slope method. Oxygen pulse 
(pulse-O2) was defined as the amount of oxygen 
consumed per systole. The ventilatory equivalent 
for oxygen (VE/VO2) was defined as the amount 
of ventilation needed for uptake of a given amount 
of oxygen. The ventilatory equivalent for carbon 
dioxide was defined as the amount of ventilation 
needed for elimination of a given amount of carbon 
dioxide. The RER was calculated by dividing the 
VO2 by VCO2. The HR reserve was calculated as 
the difference between peak and resting HR. The 
single ventricular ejection fraction (SVEF), valvu-
lar competence, and presence of fenestrations was 
noted and semi-quantified on echocardiography 
(Vivid 7 GE Medical System, USA).
Pulmonary function tests
Patients participating in the study under-
went whole-body plethysmography. The American 
Thoracic Society/European Respiratory Society 
guidelines were followed for all lung functional 
measurements [15]. Pulmonary functions were ex-
pressed as absolute values and percentage of pre-
dicted values (%N) based on the age, sex, height, 
and race of participants. The following parameters 
were noted: total life capacity (TLC), vital capac-
ity (VC), forced expiratory volume in one second 
(FEV1), forced vital capacity (FVC), tidal volume 
(TV), expiratory reserve volume (ERV), reserve 
volume (RV), peak expiratory flow (PEF); maximal 
expiratory flow (MEF), and total resistance (Rtot). 
Quality of life assessment
Quality of life was assessed with the Short 
Form-36 questionnaire (license number: QM03-
3795) [16]. It consists of 36 items divided into eight 
domains: physical functioning (PF), role-physical 
functioning (RP), bodily pain (BP), general health 
(GH), vitality (VT), social functioning (SF), role-
emotional functioning (RE), and mental health 
(MH), which are created as the weighted sums of 
questions in their section. Then, a score between 
0 and 100 is calculated for each domain on the as-
sumption that each question carries equal weight. 
The physical (PCS) and mental (MCS) component 
summary is calculated as the average value of four 
clustered domains (PF+RP+BP+VT for PCS; 
SF+RE+MH+GH for MCS). 
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Statistical analysis
Categorical variables were expressed as fre-
quency and percentage; continuous variables were 
expressed as mean and standard deviation. The 
conformity of continuous variables to the normal 
distribution was analyzed with the Shapiro-Wilk 
test. The c2 test, Mann-Whitney U test, Student’s 
t-test, and Kruskal-Wallis test were performed 
where appropriate. Individual parameters were 
calculated by use of the Spearman rank test. The 
factors determining PF and RP were analyzed by 
the use of multiple logistic regression analyses. 
Statistical significance was set at p-value 0.05. 
Statistica version 10.0.1011.7 (StatSoft Inc., USA) 
was used to analyze data. 
Results
Patients’ characteristic  
and laboratory test results
Forty patients with Fontan procedure (mean 
age 26 ± 6; 40% female) were included in this study. 
Mean age of patients at time of the procedure was 
4.8 ± 3.2 (2–14) years, and mean postoperative time 
was 20.5 ± 5.3 (14–31) years. Twenty five (62%) 
patients had right ventricular hypoplasia, 9 (23%) had 
pulmonary stenosis with transposition of the great 
arteries, 3 (8%) left ventricular hypoplasia, 2 (5%) had 
double inlet right ventricle, and 1 (2%) had a complete 
atrioventricular canal. In addition to Fontan operation, 
direct right atrium–pulmonary artery connection was 
made in 4 (10%) patients, and total cavopulmonary 
connection by means of intra-atrial lateral tunnel was 
made in the remaining patients. The single ventricle 
was on the left in 37 (93%) patients and on the right 
in 3 (7%) patients. Fenestration was seen in 20 (50%) 
patients. At the last follow-up, 9 (22%) patients 
were in NYHA class I, 28 (70%) were in NYHA 
class II, and 3 (8%) were in NYHA class III. Mean 
oxygen saturation, measured by pulse oximetry, was 
89.1 ± 6.5%. The laboratory test results of partici-
pants are given in Table 1. Analyzing a sociodemo-
graphic status of Fontan patients, most of them (89%) 
were unmarried, 26% had a university diploma and 
54% had a secondary school degree. Only 34% of 
patients were employed, 49% were unemployed, and 
17% were studying.
Echocardiography and exercise  
performance
Patient mean ejection fraction was 51.5 ± 
± 7.1%. Atrioventricular regurgitation was mild in 
18 (45%) patients, moderate in 11 (28%) patients, 
and severe in 3 (7%) patients. As seen in Table 2, 
CPET showed significant differences between 
Fontan patients and controls in T, HR, maximal 
VO2, VE, VE/VO2,VE/VCO2, BR, and RER. 
Pulmonary function testing
Results of the pulmonary function tests are 
shown in Table 2. Restrictive lung dysfunction was 
seen in 61% of Fontan patients: 62% had mild, 32% 
had moderate, and 6% had medium-severe dysfunc-
tion. There were significant differences between 
Fontan patients and controls in dynamic ventilator 
parameters including: TLC (4.8 ± 1.3 vs. 5.74 ± 0.9 L; 
p = 0.01), FEV1 (3 ± 1 vs. 3.7 ± 0.7 L; p = 0.01), 
FEV1/FVC (88.4 ± 5.9 vs. 103.2 ± 8.4%; p < 0.001), 
VC (3.5 ± 1.2 vs. 4.3 ± 0.9 L; p = 0.025), FVC 
(3.4 ± 1.2 vs. 4.3 ± 0.8 L; p = 0.02), ERV (1.1 ± 
± 0.6 vs. 1.5 ± 0.4 L; p = 0.04), and Rtot (0.5 ± 0.2 
vs. 0.3 ± 0.09 kPa/(l/s); p = 0.007).
Table 1. Laboratory test results in Fontan patients and control.
Variable (normal value) Fontan patients Control P
RBC (3.7–5.1 × 109/µL) 5.52 ± 0.5 4.8 ± 0.4 < 0.001
Hematocrit (37–47%) 47.6 ± 4.4 42.1 ± 3 < 0.001
Hemoglobin (12–16 g/dL) 16.2 ± 1.8 14.2 ± 1.2 < 0.001
RDW (11.5–14.5%) 14.6 ± 2.5 12.8 ± 0.5 < 0.001
Ferrum (11–28 µmol/L) 17.2 ± 7.4 19.4 ± 6.4 < 0.224
BNP (< 125 pg/mL) 493.1 ± 725.2 41.2 ± 25.9 < 0.001
Albumin (32.4–52.8 g/L) 44.3 ± 6,4 48.5 ± 2.2 0.005
ALT (< 33 U/L) 28.5 ± 12 21 ± 6 0.006
Creatynin (40–88 µmol/L) 77.6 ± 18 78.3 ± 13 0.784
Cystatin C (0.56–0.9 mg/L) 1.0 ± 0.3 0.84 ± 0.12 0.001
RBC — red blood cells; RDW — red cell distribution width; BNP — B-type natriuretic peptide; ALT — alanine aminotransferase
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Quality of life
The perceived physical and mental domains of 
health were significantly different between Fontan 
patients and controls (Table 3). There were no dif-
ferences between men and women in either group. 
PF, RP, BP, GH, and RE were significantly different 
in Fontan patients compared with controls. PCS 
and MCS were significantly lower in patients than 
in controls. There was no relationship of patient 
QOL with any of the following: age, age at Fontan 
operation, time since surgery, type of operation, 
presence of fenestration, type of systemic ventricle 
(left or right), and oxygen saturation at rest. Ad-
ditionally, echocardiographic data, including SVEF 
and atrioventricular regurgitation, and laboratory 
test results (other than those described below) did 
not correlate with QOL scores.  
The relationship between hepatic dysfunc-
tion and QOL was assessed after stratification of 
patients based on liver tests. Serum albumin levels 
Table 2. Cardiopulmonary exercise test (CPET) and pulmonary function test results in Fontan patients 
and control. 
Parameter Fontan patients Control P
CPET
T [min:s] 14:33 ± 02:43 16:52 ± 02:44 < 0.001
Heart rate [bpm] 151.2 ± 26.5 178.4 ± 22.3 < 0.001
Maximum VO2 [mL/kg/min] 22.9 ± 7.1 48.8 ± 7.5 < 0.001
VE [L/min] 54.4 ± 18.1 112.4 ± 28.2 < 0.001
VE/VO2 33.1 ± 5.8 29 ± 3.9 0.001
VE/VCO2 31.6 ± 3.7 26.6 ± 3.1 < 0.001
BR [L/min] 75 ± 19.4 41.4 ± 17.2 < 0.001
RER 1.05 ± 0.1 1.1 ± 0.1 0.04
Pulmonary function test  
TLC [L] 4.8 ± 1.3 5.74 ± 0.9 0.01
TLC [%N] 77.7 ± 11.8 98.5 ± 6.8 < 0.001
FEV1 [L] 3.0 ± 1 3.7 ± 0.7 0.01
FEV1 [%N] 76.9 ± 18.2 103.2 ± 8.3 < 0.001
VC [L] 3.5 ± 1.2 4.3 ± 0.9 0.025
VC [%N] 72.1 ± 19.1 98.9 ± 9.1 < 0.001
FVC [L] 3.4 ± 1.2 4.3 ± 0.8 0.02
FVC [%N] 74,4 ± 16.9 100.1 ± 8.6 < 0.001
FEV1%VC [%] 88.4 ± 6.0 87.8 ± 5 0.25
FEV1%VC [%N] 104.2 ± 7.4 105.6 ± 5.7 0.30
FEV1%FVC [%] 88.4 ± 5.9 103.2 ± 8.4 < 0.001
FEV1%FVC [%N] 103.6 ± 7.7 102.9 ± 5.8 0.92
TV [L] 0.8 ± 0.4 0.8 ± 0.4 0.98
TV [%N] 177 ± 75.1 177 ± 79.1 0.98
ERV [L] 1.1 ± 0.6 1.5 ± 0.4 0.04
ERV [%N] 75.8 ± 32.6 109.7 ± 26 0.004
RV [L] 1.3 ± 0.3 1.4 ± 0.2 0.06
RV [%N] 85.9 ± 18.3 93.5 ± 12.1 0.08
RV/TLC 28.7 ± 7.6 25 ± 4.1 0.41
RV/TLC [%N] 111.2 ± 29.6 93.5 ± 13 0.06
Rtot [kPa/(l/s)] 0.5 ± 0.2 0.3 ± 0.09 0.007
Rtot [%N] 159 ± 71.3 102.7 ± 29 0.004
T — exercise time; VO2 — oxygen uptake; VE — ventilatory equivalent; VCO2 — CO2 production; BR — breath reserve; RER — respiratory 
exchange ratio; TLC — total life capacity; FEV1 — forced expiratory volume in 1 s; VC — vital capacity; FVC — forced vital capacity; TV — tidal 
volume; ERV — expiratory reserve volume; RV — reserve volume; Rtot — total resistance
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were associated with better PF and RP (rS = 0.399 
and 0.374, respectively). PF and GH were nega-
tively associated with ALT (rS = –0.374 and –0.373, 
respectively). QOL scores were not significantly 
associated with serum creatinine or cystatin C. 
None of the CPET variables was correlated 
with QOL scores with the exception of maximal 
HR at the peak of exercise which was related to PF 
(rS = 0.414) (Table 4). There was no relation be-
tween QOL scores, including the PCS, and VO2max. 
There was no correlation between PF and TLC, 
in spite of a reduced TLC in 61% of patients (Ta-
ble 4). However, PF was related to dynamic lung 
volumes, including FEV1 (rS = 0.45), FEV1 (%N) 
Table 3. Mann-Whitney U test (c2 test for gender) results for the Short Form-36 questionnaire in Fontan 
patients and controls.
Fontan patients Controls   P
Age [years] 25.3 ± 6.0 26.7 ± 3.2 0.518
Gender — male 24 (60%) 20 (50%) 0.368
Physical functioning 68.8 ± 24.3 97 ± 4.6 < 0.001
Role physical 68.7 ± 38 93.7 ± 16.5 < 0.001
Bodily pain 71.7 ± 25.7 82.9 ± 20.2 0.034
General health 45.1 ± 23 78.2 ± 15 < 0.001
Vitality 58.9 ± 18.9 63.9 ± 14.8 0.177
Social functioning 80.6 ± 21.6 86.4 ± 16.4 0.069
Role emotional 74 ± 40 94.2 ± 18.3 0.009
Mental health 70 ± 19.1 73.3 ± 15.7 0.494
Mental complex status 67.4 ± 20.8 83.4 ± 11.6 < 0.001
Physical complex status 67 ± 20.5 84.4 ± 10.9 < 0.001
Table 4. Correlation test results for Short Form-36 questionnaire.
Variable PF RP GH PCS MCS
CPET
T 0.269 0.359 0.130 0.257 0.307
HR 0.414 0.271 0.208 0.033 0.249
VO2 0.064 0.131 0.021 0.044 0.140
Pulmonary function test  
FEV1 0.453 0.187 -0.004 0,026 0.087
FEV1 [%N] 0.549 0.332 0.220 0.158 0.259
VC 0.378 0.160 -0.030 -0.013 0.041
VC [%N] 0.447 0.279 0.140 0.084 0.174
FVC 0.371 0.135 -0.041 -0.042 0.031
FVC [%N] 0.513 0.305 0.183 0.099 0.220
VT 0.425 0.389 0.277 0.393 0.356
VT [%N] 0.487 0.412 0.325 0.393 0.474
ERV 0.452 0.212 0.093 -0.062 0.186
ERV [%N] 0.501 0.296 0.240 0.058 0.323
RV%TLC –0.343 –0.467 0.214 0.266 0.026
RV%TLC [%N] –0.290 –0.076 0.222 0.259 –0.012
CPET — cardiopulmonary exercise test; T — exercise time; VO2 — oxygen uptake; FEV1 — forced expiratory volume in 1 s; VC — vital capacity; 
FVC — forced vital capacity; VT — vitality; ERV — expiratory reserve volume; RV — recerve volume; TLC — total life capacity; PF — physical 
functioning; RP — role physical; GH — general health; PCS — physical complex status; MCS — mental complex status
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(rS = 0.55), VC (%N) (rS = 0.45), FVC (%N) 
(rS = 0.51), VC (%N) (rS = 0.447), VT (rS = 0.42), 
VT (%N) (rS = 0.49), PEF (rS = 0.42), PEF (%N) 
(rS =  0.53), ERV (rS =  0.45), and ERV (%N) 
(rS = 0.5). PF also was significantly correlated with 
lung distension ratio (rS = –0.34). RP was related 
to VT (%N) (rS = 0.412), which influences the GH 
and PCS. Employment and social status, marital 
status, and level of education did not influence the 
perceived health-related QOL.
To determine the relationship between self-
perceived QOL and cardiopulmonary function 
test, ventilatory parameters and liver dysfunction, 
a stepwise regression analysis was performed 
with PF and RP as dependent variables. The 
multivariate model showed that maximal HR 
at the peak of CPET (b = 0.59, p = 0.002) was 
an independent predictor of physical function-
ing (r2 = 0.35, p = 0.02) (Fig. 1). Additional-
ly, serum albumin level (b = 0.47, p = 0.02) 
was an independent predictor of RP (r2 = 0.22, 
p = 0.02) (Fig. 2).
Discussion
Self-perceived QOL, in addition to long-term 
morbidity, is an important outcome in patients with 
a single ventricle. Patients with well-controlled 
CHD (adult and children) were reported to have 
QOL comparable to that in healthy individuals [17]. 
However, the QOL in complex or cyanotic CHD is 
reportedly poor [18], it was also found that patient 
subjective QOL assessment was corroborated by 
objective laboratory and imaging results. 
Underlined physical functioning was positively 
correlated with maximal HR at the peak of exer-
cise. Maximal HR at the peak of exercise was an 
independent predictor of PF. Recent data show that 
physical activity in patients with Fontan physiology 
is limited by an increased ventricular preload and 
inadequate cardiac output [19]. In healthy persons, 
cardiac output at rest depends on HR, contractil-
ity, afterload, and preload. Exercise increases the 
cardiac output up to 5-fold or more due to the 
augmentation of the above components. In Fontan 
circulation, the lack of a pulmonary pump reduces 
the return from pulmonary circulation [20]. As 
a result, preload reserve of the systemic ventricle 
is reduced or absent. Cardiac output in Fontan 
circulation at rest is 70% of cardiac output of the 
biventricular heart [21]. Additionally, chronotropic 
incompetence occurs during exercise in patients 
with Fontan circulation [20], with an HR consist-
ently lower than in normal subjects. This situation 
is due to abnormal reflex control of HR and adr-
energic dysfunction [20, 22]. Heart rate plays an 
important role in determining the cardiac output in 
Fontan circulation during exercise [19, 20], when 
autonomic dysfunction of the sinus node leads to 
a relatively low HR [23]. Physical functioning, 
including vigorous activities like running, lifting 
heavy objects, or strenuous sports, and mild ac-
tivities like bending, kneeling, lifting, or carrying 
groceries, depends on maximal HR reached at the 
peak of exercise. In this study, a lower peak HR 
was associated with worse general health and role 
physical. Recent studies show that Fontan patients 
with severely impaired SVEF have decreased 
Figure 2. Correlation between albumin level and role 
physical in Fontan patients. Blue dotted line indicates 
the 95% confidence interval.
Figure 1. Correlation between heart rate level and physi-
cal functioning in Fontan patients. Blue dotted line indi-
cates 95% confidence interval.
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cardiac output, whereas patients with moderately 
impaired SVEF have normal cardiac output [19]. 
The mean SVEF of patients was 51.5 ± 7%, and 
SVEF and PF were not correlated. 
Self-perceived PF was related to dynamic 
ventilatory parameters on body plethysmography. 
Data on respiratory dysfunction in adult Fontan 
patients are limited. Some studies show that 
Fontan patients may develop a restrictive lung 
disease [23–25] due to weak respiratory muscles, 
restrictive thoracic cage, or paralysis of the dia-
phragm after surgery. Previous studies have shown 
reduced ventilator parameters such as: TLC, 
FEV1, VC, FVC, PEF, MEF25, MEF50, and MEF75 in 
Fontan patients compared with those functions in 
healthy controls and predicted values [26]. Reduced 
dynamic lung volumes, which depend on respira-
tory muscle strength, influence the self-perceived 
physical functioning of patients. Respiratory mus-
cle strength can be improved with therapeutic 
intervention and pulmonary rehabilitation. The 
impact of pulmonary rehabilitation on QOL has 
not been studied. Several studies report increased 
respiratory muscle strength and exercise capac-
ity with resistance training in adults with Fontan 
circulation [27–31]. Even though exercise training 
is well-established as a non-pharmacologic therapy 
in cardiac patients, its impact on self-perceived 
physical functioning remains insufficiently clear 
in patients after CHD surgery. 
In this study, PF was associated with liver 
impairment. Hepatic complications may develop 
in patients with Fontan circulation, including chol-
estasis, fibrosis, hepatomegaly, and cirrhosis [32]. 
There are limited data on QOL of patients who have 
liver diseases, especially end-stage liver disease, 
with or without cardiac disease [33–36]. This 
study evaluated the QOL of Fontan patients with 
liver dysfunction. It was found that self-perceived 
physical function and general health were related to 
ALT levels. Patients with increased ALT levels had 
worse physical functioning, role physical, general 
health and physical complex status compared with 
those values in patients with normal ALT levels.  
Role physical component was defined as prob-
lems with work or other daily activities as a result 
of physical health. In the present study, role physi-
cal correlated with tidal volume measured on body 
plethysmography and serum albumin levels. Serum 
albumin level was also an independent predictor of 
role physical. Six percent of patients had low serum 
albumin levels. Protein-losing enteropathy is a rare 
complication of Fontan circulation with very poor 
diagnosis [37, 38].
Although only the role emotional domain of 
the Short Form-36 questionnaire was reduced in 
this study, the mental complex status and physical 
complex status were also significantly lower than 
in controls. This finding contrasts with that of 
a previous study in which the mental status of the 
patients was normal [13, 39]. Bordin et al. [40] con-
cluded that Fontan patients are aware of, tolerate, 
and accept their physical limits, and their mental 
condition is influenced by their functional status 
only when it prevents daily life activities. The dif-
ferences in these results can be explained by taking 
into account the NYHA class; in this study, 70% of 
patients were in NYHA class II and 7.5% were in 
NYHA class III. Therefore, severity of the disease 
does not influence the perceived QOL unless it 
interferes with the daily activities. Psychological 
analysis of patients may be used to explore these 
mental differences and ascribe a cause to limitation 
in daily activities. Most patients in this study had 
a high school diploma, and almost a quarter had 
a university degree. There was a high rate of unem-
ployment (almost 50%), which is almost 5 times 
higher than in the general Polish population. These 
findings are in line with the results of a previous 
study [40]. Physical limitations are responsible 
for the inability of these patients to work; thus 
they may require additional social assistance. The 
social status of patients and their relatively young 
age probably explain why only 11% were married 
or had a partner. 
Limitations of the study
The following limitations of this study are 
acknowledged. First, the sample size was small 
and heterogeneous in initial diagnoses and type 
of Fontan surgery. Second, the QOL was assessed 
by only a single standardized questionnaire, Short 
Form-36. Third, the liver function was assessed 
indirectly by commonly used markers, not by 
quantitative measures.
Conclusions
The study results indicate, that self-perceived 
QOL and physical status of patients who underwent 
Fontan procedure was mostly related to incompe-
tence during exercise (as illustrated by the dynamic 
parameters of ventilation and maximal HR in re-
sponse to physical fatigue) and to liver impairment 
associated with protein-losing enteropathy. Adult 
Fontan patients are a special, heterogeneous group 
requiring careful multidisciplinary and subjective 
assessment of their QOL.
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Liver impairment and chronotropic incompe-
tence during exercise are main factors that lead to 
worsening of the QOL, and should be monitored in 
long-term follow-up. 
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